Covered recipient · General Payments record
DZUNG M NGUYEN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Primary Care
General Payments · PY2021–2024
$585.17
- Reported across 25 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $401.22 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $146.28 | 4 |
| Lilly USA, LLC | $66.28 | 2 |
| Paratek Pharmaceuticals, Inc. | $40.27 | 2 |
| Amgen Inc. | $35.77 | 2 |
| Merck Sharp & Dohme Corporation | $33.94 | 2 |
| Novo Nordisk AS | $32.32 | 2 |
| Regeneron Healthcare Solutions, Inc. | $30.68 | 1 |
| Exact Sciences Corporation | $15.68 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $22.04 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117641101 | CMS |
| Amgen Inc. | $13.73 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115968264 | CMS |
| Exact Sciences Corporation | $15.68 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114521531 | CMS |
| Lilly USA, LLC | $32.54 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135614425 | CMS |
| Lilly USA, LLC | $33.74 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135575326 | CMS |
| Merck Sharp & Dohme LLC | $17.19 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141712523 | CMS |
| Merck Sharp & Dohme LLC | $16.75 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141931411 | CMS |
| Novo Nordisk Inc | $17.06 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100468458 | CMS |
| Novo Nordisk Inc | $15.26 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100423586 | CMS |
| Paratek Pharmaceuticals, Inc. | $17.80 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113932104 | CMS |
| Paratek Pharmaceuticals, Inc. | $22.47 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113932106 | CMS |
| Regeneron Healthcare Solutions, Inc. | $30.68 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114349215 | CMS |
| UCB, Inc. | $35.29 | 08/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143033359 | CMS |
| UCB, Inc. | $38.74 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143033361 | CMS |
| UCB, Inc. | $32.50 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143033363 | CMS |
| UCB, Inc. | $39.75 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143033365 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.